FD

Fondation d'Aide aux Entreprises

Europe, Geneve, Switzerland, Plan-les-ouates

Description

Fondation d'Aide aux Enterprises is a company that provides corporate financing services.

Investor Profile

Fondation d'Aide aux Entreprises has made 3 investments, with 0 in the past 12 months and 0% as lead.

Stage Focus

  • Angel (67%)
  • Series C (33%)

Country Focus

  • Switzerland (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Pharmaceutical
  • Internet Of Things
  • Network Security
  • Software
  • Telecommunications
  • Artificial Intelligence (Ai)
  • Brand Marketing
  • Content Marketing
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Fondation d'Aide aux Entreprises frequently co-invest with?

Sophia Business Angels
Europe, Provence-Alpes-Cote d'Azur, France, Valbonne
Co-Investments: 1
Andera Partners
Europe, Ile-de-France, France, Paris
Co-Investments: 1
Verve Ventures
Europe, Zug, Switzerland, Zug
Co-Investments: 1
Vesalius Biocapital Partners
Europe, Luxembourg, Luxembourg, Strassen
Co-Investments: 1
Galata Business Angels
Europe, Istanbul, Turkey, Istanbul
Co-Investments: 1
MP Healthcare Venture Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
3wVentures
Europe, Ausser-Rhoden, Switzerland, Herisau
Co-Investments: 1
F
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1
Eclosion SA
Europe, Geneve, Switzerland, Geneva
Co-Investments: 1

What are some of recent deals done by Fondation d'Aide aux Entreprises?

Orbiwise

Plan-les-ouates, Geneve, Switzerland

Orbiwise is a Swiss company that develops advanced technologies for the Internet of Things industry.

Internet of ThingsNetwork SecuritySoftwareTelecommunications
AngelSep 22, 2016
Faveeo

Geneva, Geneve, Switzerland

Faveeo is the first AI-Driven trusted content platform.

Artificial Intelligence (AI)Brand MarketingContent MarketingDigital MarketingPublishing
AngelNov 1, 2014
Amount Raised: $800,000
Genkyotex

Geneva, Geneve, Switzerland

Genkyotex develops innovative drugs to block the NOX enzymes that produce oxygen radicals.

BiotechnologyHealth CarePharmaceutical
Series CMay 24, 2011
Amount Raised: $20,400,000